An immune origin of type 2 diabetes?

Kolb, H., Mandrup-Poulsen, T.·2005·Diabetologia
DOI 10.1007/s00125-005-1764-9

Cites (225)

Items 201–226 of 226

  1. Troglitazone reduces plasma levels of tumour necrosis factor‐α in obese patients with type 2 diabetes
    Akira Katsuki, Yasuhiro Sumida, Kazuya Murata, Masahiko Furuta, Rika Araki-Sasaki, Ken Tsuchihashi, Yasuko Hori, Yutaka Yano, Esteban Cesar Gabazza, Yukihiko Adachi · 2000 · Diabetes Obesity and Metabolism
  2. Macrophages and pancreatic islet amyloidosis
    Eelco J.P. de Koning, Joop van den Brand, Victoria L. Mott, SOPHIE B. P. CHARGÉ, Barbara C. Hansen, Noni L. Bodkin, John F. Morris, Anne Clark · 1998 · Amyloid
  3. Should antioxidant status be considered in interventional trials with antioxidants?
    Francesco Violi, Lorenzo Loffredo, L Musella, Antonella Marcoccia · 2004 · Heart
  4. Genetic manipulation of insulin signaling, action and secretion in mice
    Anne Baudry, Loïc Leroux, Malene Jackerott, Rajiv L. Joshi · 2002 · EMBO Reports
  5. Diet and C-reactive protein
    Peter Marshall Clifton · 2003 · Current Atherosclerosis Reports
  6. HLA-associated susceptibility to Type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study
    Stephen S. Rich, Lindsey French, J. Michael Sprafka, J. P. Clements, F. C. Goetz · 1993 · Diabetologia
  7. Pathophysiology of insulin secretion
    André Jacques Scheen · 2004 · Annales d Endocrinologie
  8. Prospective Relation of C-Reactive Protein With Type 2 Diabetes
    Marieke Brigitte Snijder, Jacqueline M. Dekker, Marjolein Visser, Coen D.A. Stehouwer, John S Yudkin, L.M. Bouter, Robert J. Heine, Giel Nijpels, Jacob C. Seidell · 2003 · Diabetes Care
  9. Serumglykoproteine beim Diabetes mellitus; quantitative immunologische Bestimmung von saurem ?1-Glykoprotein, Gc, ?2-Makroglobulin und H�mopexin bei Diabetikern mit und ohne Angiopathien
    Hartwig Clevė, Kyle G. Alexander, H J Mitzkat, P. Nissen, I. Salzmann · 1968 · Diabetologia
  10. Relationship between B-cell function and HLA antigens in patients with Type 2 (non-insulin-dependent) diabetes
    Leif Groop, Per‐Henrik Groop, S. Koskimies · 1986 · Diabetologia
  11. Blood Viscosity, Serum Hexosamine and Diabetic Retinopathy
    David Glendenning Cogan, LORENZO O. MEROLA, Peter R. Laibson · 1961 · Diabetes
  12. Changes in serum proteins and protein-bound carbohydrates in diabetes mellitus
    D. E. McMillan · 1970 · Diabetologia
  13. Mechanisms of Defective Glucose-Induced Insulin Release in Human Pancreatic Islets Transplanted to Diabetic Nude Mice1
    Decio Laks Eizirik, Leif E. Jansson, Malin Flodström‐Tullberg, Claes Hellerström, Arne Andersson · 1997 · The Journal of Clinical Endocrinology & Metabolism
  14. Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in man
    Michael Krebs, Margarethe Geiger, Kaija Polak, Anja Vales, Leopold F. Schmetterer, Oswald F Wagner, Werner K Waldhäusl, Michael Roden, Bernd R. Binder · 2003 · Thrombosis and Haemostasis
  15. IL-10 induces gene expression in macrophages: partial overlap with IL-5 but not with IL-4 induced genes
    R. Stumpo, Manfred Kauer, Stéphan Martin, Hubert Kolb · 2003 · Cytokine
  16. Fatty acids potentiate interleukin-1β toxicity in the β-cell line INS-1E
    M Aarnes, Svanhild Arentz Schønberg, Valdemar Grill · 2002 · Biochemical and Biophysical Research Communications
  17. Islet β-Cell Apoptosis Triggeredin Vivoby Interleukin-1β Is Not Related to the Inducible Nitric Oxide Synthase Pathway: Evidence for Mitochondrial Function Impairment and Lipoperoxidation
    Matilde Todaro, Francesca Di Gaudio, Marialuisa Lavitrano, Giorgio Stassi, Gianpaolo Papaccio · 2003 · Endocrinology
  18. Serum haptoglobin in juvenile diabetes
    CARL GUSTAF BERGSTRAND, P. Fuurst, Y Larsson, G Sterky · 1962 · Scandinavian Journal of Clinical and Laboratory Investigation
  19. A tumor necrosis factor-β polymorphism associated with hypertriglyceridemia in non-insulin-dependent diabetes mellitus
    Joan Josep Vendrell, Cristina Gutiérrez, R Pastor, Cristóbal Richart · 1995 · Metabolism
  20. Carboxypeptidase E and obesity in the mouse
    Edward H. Leiter · 1997 · Journal of Endocrinology
  21. METFORMIN INCREASES CIRCULATING TUMOUR NECROSIS FACTOR α LEVELS IN NON-OBESE NON-DIABETIC PATIENTS WITH CORONARY HEART DISEASE
    Sven Magnus Carlsen, Anders Waage, Valdemar Grill, Ingrid Sørdal Følling · 1998 · Cytokine
  22. Cytokine Polymorphisms in Chronic Inflammatory Diseases with Reference to Occupational Diseases
    Berran Yücesoy, Michael L. Kashon, Michael I. Luster · 2003 · Current Molecular Medicine
  23. The Independence of Signaling Pathways Mediating Increased Expression of Plasminogen Activator Inhibitor Type 1 in HepG2 Cells Exposed to Free Fatty Acids or Triglycerides
    Yabing Chen, David J. Schneider · 2001 · Journal of Diabetes Research
  24. Serum haptoglobin in juvenile diabetes
    CARL GUSTAF BERGSTRAND, P. Fuurst, Y. Larsson · 1962 · Scandinavian Journal of Clinical and Laboratory Investigation
  25. Protective effect of DRB1 locus against type 2 diabetes mellitus in Mexican Mestizos
    Elva Leticia Pérez-Luque, Carmen Alaez, Juan Manuel Malacara, Ma. Eugenia Garay‐Sevilla, Martha Eugenia Fajardo, Laura Eugenia Nava, Clara Gorodezky · 2002 · Human Immunology
  26. Increased and decreased relative risk for noninsulin‐dependent diabetes mellitus conferred by HLA class II and by CD4 alleles
    M. Zamani Ghabanbasani, Marijke Spaepen, Inge M. Buyse, Eric Legius, Ronny Decorte, M Bex, Peter Marynen, Roger Bouillon, Jean‐Jacques Cassiman · 1995 · Clinical Genetics